Semaglutide in obesity-related heart failure with preserved ejection fraction and type 2 diabetes across baseline HbA1c levels (STEP-HFpEF DM): a prespecified analysis of heart failure and metabolic outcomes from a randomised, placebo-controlled trial

待确认 10 由 xiaoxiao 发布于 2025/1/23 9:39:19

DOI:10.1016/s2213-8587(24)00304-8
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1016/s2213-8587(24)00304-8

Elsevier

Abstract：BackgroundAbout half of patients with heart failure with mildly reduced or preserved ejection fraction (HFpEF) have type 2 diabetes. In the STEP-HFpEF DM trial of adults with obesity-related

应助信息

等待求助人确认

求助人未确认前，本求助不能再次应助。36小时后系统将自动确认应助成功。本求助将自动关闭。

2小时前

heqiang

b52e8b78d95a11ef932b34735aa3bc31.pdf

7小时前

Book学术机器人

2025/1/23 9:39:19 未找到该文献，机器人已退出，请等待人工下载

2025/1/23 9:39:19 Book学术AI机器人收到请求，开始寻找文献

2025/1/23 9:39:19 已向机器人发送请求

7小时前

xiaoxiao 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:NatureMicrobial extracellular polymeric substances in the environment, technology and medicine